2MOULIK P K, NETHAJI C, KHALEELI A A, et al. Misleading electrocardiographic resuif in patient with hyperkalemia and diabetic katoaeidosis results of electrocardiography may mimic myocardial infarction in patients with severe metabolic disturbance[J]. BMJ, 2002,325: 1346 - 1347.
3McAlister FA, Ezekowitz J, Tonelli M, et al.Renal insufficiency and heart failure : prognostic and therapeutic implications from a prospective cohort study[J]. Circulation, 2004,109(8):1004.
4Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin Ⅱ receptor blockers to halt progression of chronic renal disease:Pathophysiology and indications[J]. Kidney Iht, 2005, 67(3):799.
5Anton C, Cox AR, Watson RD, et al. The safety of spironolactone treatment in patients with heart failure[J]. J Clin Pharm Ther, 2003, 28(4):285.
6Bakris GL, Siomos M, Richardson D, et al. ACE inhibition or angiotensin receptor blockade:impact on potassium in renal failure [J]. Kidney Int, 2000, 58(5):2084.
7Cruz CS, Cruz AA, Marcilio de Souza CA. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone[J].Nephrol Dial Transplant, 2003, 18(9):1814.
8Schepkens H, Vanholder R, Billiouw JM, et al.Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25cases[J]. Am J Med, 2001, 110(6):438.
9Platts - Mills TF, Richmond NL, Hunold KM, et al. Life - threat- ening hyperkalemia after 2 days of ibuprofen. Am J Emerg Med, 2013,31 (2) :465. el - e2.
10Chelcun JL, Sable RA, Friedman K. Colonic ulceration in a pa-tient with renal disease and hyperkalemia. JAAPA,2012,25 (10) :34,37 -38.
